Publication | Open Access
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
133
Citations
26
References
2020
Year
EudraCT: 2005-005362-36 CLINICALTRIALS.GOV:: NCT00355862.
| Year | Citations | |
|---|---|---|
Page 1
Page 1